HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Q1

This article was originally published in The Rose Sheet

Executive Summary

Personal care sales in the first quarter increased 8% to $2.8 bil. at constant rates on strong performance of hair care, skin care and deodorants, which advanced 11% during the period, Unilever states in 1sales and earnings announcement May 2. Operating profit before exceptional items and amortization of goodwill and intangibles was up 1% to $548 mil., the company adds. North American personal care sales rose 5% on the strength of Dove hair care, Axe antiperspirants/deodorants, which is being expanded with new fragrances, VP-Investor Relations Howard Green reports. Prestige fragrances experienced flat performance in the quarter, with strong sales of Vera Wang and Crave scents offset by weakness in travel retail...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011180

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel